EUVIMEDOpdag EUVIMED
KohortenstudieOpen access · CC BY-NC-ND 4.0

Evaluation of Medication Adherence Among Prevalent Users in Hypertension, Dyslipidemia, and Diabetes Using Health Insurance Claims: A Population‐Based Cohort Study in Japan

Minako Matsumoto iD, Sei Harada, Harufumi Ikuta, Miho Iida, Suzuka Kato, Mizuki Sata, Takuma Shibuki, Yoshiki Ishibashi, Naoko Miyagawa, Moeko Hisamatsu, Aya Hirata, Kazuyo Kuwabara and 6 more

Pharmacoepidemiology and Drug Safety · 2024

DOI: 10.1002/pds.5855 ↗

At a glance

Kohortenstudie in Pharmacoepidemiology and Drug Safety, 2024. Written by Minako Matsumoto and 17 co-authors. Institution: Department of Preventive Medicine, Public Health, Keio University School of Medicine, Tokyo, Japan. Major MEDLINE topics: Dyslipidemias, Hypertension, Diabetes Mellitus, Drug Monitoring. Cited 2 times so far (Crossref); 35 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Yamagata Prefectural Government, City of Tsuruoka, Japan Society for the Promotion of Science.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Purpose

Hypertension (HT), dyslipidemia (DL), and diabetes mellitus (DM) are major risk factors for cardiovascular diseases. Despite the wide availability of medications to reduce this risk, poor adherence to medications remains an issue. The aim of this study is to evaluate medication adherence of prevalent users in these disease medications (HT, DL, DM) using claims data. Factors associated with non‐adherence were also examined.

Methods

Of 7538 participants of the Tsuruoka Metabolomics Cohort Study, 3693 (HT: 2702, DL: 2112, DM: 661) were identified as prevalent users of these disease medications. Information on lifestyle was collected through a questionnaire. Adherence was assessed by a proportion of days covered (PDC) and participants with PDC ≥0.8 were defined as adherent. Predictors of non‐adherence were determined by performing multivariable logistic regression.

Results

Medication adherence differed by treatment status. Among those without comorbidities, those with HT‐only showed the highest adherence (90.2%), followed by those with DM‐only (81.2%) and those with DL‐only (80.8%). Factors associated with non‐adherence in each medication group were skipping breakfast and poor understanding of medications among those with HT medications, females, having comorbidities, having a history of heart disease, and drinking habit among those with DL medications, and good sleep quality and skipping breakfast among those with DM medications.

Conclusion

While participants showed high medication adherence, differences were observed across medication groups. The identified predictors of non‐adherence could help target those in need of adherence support.

Subjects

MeSH terms (MEDLINE)

DyslipidemiasHypertensionDiabetes MellitusDrug MonitoringHumansFemaleMaleJapanMiddle AgedCohort StudiesAgedAdultAntihypertensive AgentsPrevalenceRisk FactorsInsurance, HealthInsurance Claim Review

Author keywords

adherencecohort‐studyhealth insurance claims datapharmacoepidemiology

Substances

Antihypertensive Agents

Authors and institutions

  • Department of Preventive Medicine, Public Health, Keio University School of Medicine, Tokyo, Japan.
  • Division of Pharmaceutical Care Sciences, Keio University Faculty of Pharmacy, Tokyo, Japan.
  • Faculty of Science and Engineering, Chuo University, Tokyo, Japan.
  • Faculty of Nursing and Medical Care and Graduate School of Health Management, Keio University, Fujisawa, Japan.

ORCID profiles: Minako Matsumoto, Toru Takebayashi

Funding

  • Yamagata Prefectural Government
  • City of Tsuruoka
  • Japan Society for the Promotion of Science

Cite

APA

Matsumoto, M., Harada, S., Ikuta, H., Iida, M., Kato, S., Sata, M., Shibuki, T., Ishibashi, Y., Miyagawa, N., Hisamatsu, M., Hirata, A., Kuwabara, K., Takeuchi, A., Sugiyama, D., Suzuki, S., Nakamura, T., Okamura, T., & Takebayashi, T. (2024). Evaluation of Medication Adherence Among Prevalent Users in Hypertension, Dyslipidemia, and Diabetes Using Health Insurance Claims: A Population‐Based Cohort Study in Japan. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.5855

Vancouver

Matsumoto M, Harada S, Ikuta H, Iida M, Kato S, Sata M, et al. Evaluation of Medication Adherence Among Prevalent Users in Hypertension, Dyslipidemia, and Diabetes Using Health Insurance Claims: A Population‐Based Cohort Study in Japan. Pharmacoepidemiology and Drug Safety. 2024. doi:10.1002/pds.5855

BibTeX
@article{Matsumoto2024,
  author = {Matsumoto, Minako and Harada, Sei and Ikuta, Harufumi and Iida, Miho and Kato, Suzuka and Sata, Mizuki and Shibuki, Takuma and Ishibashi, Yoshiki and Miyagawa, Naoko and Hisamatsu, Moeko and Hirata, Aya and Kuwabara, Kazuyo and Takeuchi, Ayano and Sugiyama, Daisuke and Suzuki, Sayo and Nakamura, Tomonori and Okamura, Tomonori and Takebayashi, Toru},
  title = {Evaluation of Medication Adherence Among Prevalent Users in Hypertension, Dyslipidemia, and Diabetes Using Health Insurance Claims: A Population‐Based Cohort Study in Japan},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2024},
  doi = {10.1002/pds.5855}
}
Start for free →